Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-
Go back to Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-| (NASDAQ: LQDA) | Delayed: 38.86 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $38.86 | 52 Week High | $ | |||
| Open | $38.86 | 52 Week Low | $ | |||
| Day High | $38.86 | P/E | N/A | |||
| Day Low | $38.86 | EPS | $ | |||
| Volume | 5,167 | |||||



